RPID RAPID MICRO BIOSYSTEMS INC revenue, earnings and financials

For the quarter ended June 30, 2026, RAPID MICRO BIOSYSTEMS INC reported revenue of $8.05M (up 10.9% from a year earlier), net income of −$12.9M and diluted EPS of −$0.27; over the last four quarters revenue was $35.2M and net income −$51.2M; for the fiscal year ended December 2025 revenue was $33.6M, up 19.7% on the year before.

RPID annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $33.6M, gross profit n/a, operating income −$47.4M, net income −$47.1M (margin -140.3%), EPS −$1.05
• Fiscal year ended Dec 2024: revenue $28.1M, gross profit n/a, operating income −$49.9M, net income −$46.9M (margin -167.2%), EPS −$1.08
• Fiscal year ended Dec 2023: revenue $22.5M, gross profit n/a, operating income −$56.6M, net income −$52.5M (margin -233.0%), EPS −$1.22
• Fiscal year ended Dec 2022: revenue $17.1M, gross profit n/a, operating income −$63.2M, net income −$60.8M (margin -354.9%), EPS −$1.43
• Fiscal year ended Dec 2021: revenue $23.2M, gross profit n/a, operating income −$47.2M, net income −$73.5M (margin -316.5%), EPS −$3.94

RPID quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $8.05M (up 10.9% year over year), net income −$12.9M, EPS −$0.27
• Quarter ended Mar 31, 2026: revenue $8.00M (up 11.1% year over year), net income −$14.3M, EPS −$0.31
• Quarter ended Dec 31, 2025 (from the annual report): revenue $11.3M (up 37.3% year over year), net income −$12.5M, EPS −$0.26
• Quarter ended Sep 30, 2025: revenue $7.84M (up 3.1% year over year), net income −$11.5M, EPS −$0.26
• Quarter ended Jun 30, 2025: revenue $7.26M (up 9.7% year over year), net income −$11.9M, EPS −$0.27
• Quarter ended Mar 31, 2025: revenue $7.21M (up 28.4% year over year), net income −$11.3M, EPS −$0.26
• Quarter ended Dec 31, 2024 (from the annual report): revenue $8.22M (up 29.7% year over year), net income −$9.67M, EPS −$0.22
• Quarter ended Sep 30, 2024: revenue $7.60M (up 23.7% year over year), net income −$11.3M, EPS −$0.26
• Quarter ended Jun 30, 2024: revenue $6.62M (up 32.3% year over year), net income −$12.6M, EPS −$0.29
• Quarter ended Mar 31, 2024: revenue $5.61M (up 11.4% year over year), net income −$13.3M, EPS −$0.31
• Quarter ended Dec 31, 2023 (from the annual report): revenue $6.34M (up 44.9% year over year), net income −$11.2M, EPS −$0.26
• Quarter ended Sep 30, 2023: revenue $6.15M (up 29.7% year over year), net income −$13.4M, EPS −$0.31
• Quarter ended Jun 30, 2023: revenue $5.00M (up 29.6% year over year), net income −$14.0M, EPS −$0.33
• Quarter ended Mar 31, 2023: revenue $5.04M (up 21.0% year over year), net income −$13.9M, EPS −$0.32
• Quarter ended Dec 31, 2022 (from the annual report): revenue $4.37M (down 16.0% year over year), net income −$16.4M, EPS −$0.39
• Quarter ended Sep 30, 2022: revenue $4.74M (down 31.3% year over year), net income −$16.3M, EPS −$0.38
• Quarter ended Jun 30, 2022: revenue $3.86M (down 37.0% year over year), net income −$13.1M, EPS −$0.31
• Quarter ended Mar 31, 2022: revenue $4.16M (down 16.7% year over year), net income −$14.9M, EPS −$0.35
• Quarter ended Dec 31, 2021 (from the annual report): revenue $5.21M, net income −$14.6M, EPS $54.67
• Quarter ended Sep 30, 2021: revenue $6.90M, net income −$25.0M, EPS −$0.71

RPID cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow −$31.1M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow −$44.2M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$45.1M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$58.5M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$55.0M, share buybacks n/a

RPID balance sheet

• Jun 30, 2026: cash $14.7M, total assets $58.5M, total liabilities $40.7M, shareholders' equity $17.7M, long-term debt $19.1M
• Mar 31, 2026: cash $13.8M, total assets $62.4M, total liabilities $42.0M, shareholders' equity $20.4M, long-term debt $19.1M
• Dec 31, 2025: cash $20.0M, total assets $74.9M, total liabilities $41.6M, shareholders' equity $33.2M, long-term debt $18.9M
• Sep 30, 2025: cash $18.9M, total assets $84.4M, total liabilities $40.1M, shareholders' equity $44.3M, long-term debt $18.8M
• Jun 30, 2025: cash $18.3M, total assets $75.6M, total liabilities $21.0M, shareholders' equity $54.5M
• Mar 31, 2025: cash $18.9M, total assets $85.4M, total liabilities $19.9M, shareholders' equity $65.5M
• Dec 31, 2024: cash $16.9M, total assets $98.2M, total liabilities $22.8M, shareholders' equity $75.4M, long-term debt $0
• Sep 30, 2024: cash $22.0M, total assets $106M, total liabilities $21.5M, shareholders' equity $84.4M

What is RPID's revenue?

RAPID MICRO BIOSYSTEMS INC reported $35.2M of revenue over its last four quarters, through June 30, 2026.

Is RPID profitable?

No. RAPID MICRO BIOSYSTEMS INC lost $51.2M over the last four quarters.

What is RPID's EPS?

Diluted earnings per share over the last four quarters were −$1.10; −$0.27 in the latest quarter.

RPID ownership and insider trades · All stocks